Items where authors include "Russell, M."

Article

Iles-Smith, H. orcid.org/0000-0002-0520-2694, McMillan, I.M. orcid.org/0000-0002-1233-2198, Evans-Cheung, T. orcid.org/0000-0003-0899-5383 et al. (8 more authors) (2023) Investigating mortality and morbidity associated with UrINary incontinence during Older Womens Secondary Care Admissions and exploring nurses experiences of delivering related care (U-INconti): a mixed methods research protocol. BMJ Open, 13 (10). e067937. ISSN 2044-6055

McMillan, I. orcid.org/0000-0002-1233-2198, Hill, L., McCarthy, R. et al. (7 more authors) (2023) Urinary incontinence in women 55 years and older: A scoping review to understand prevalence, incidence, and mortality of urinary incontinence during secondary care admission. Women's Health, 19. ISSN 1745-5057

Aggarwal, D. orcid.org/0000-0002-5938-8172, Warne, B. orcid.org/0000-0003-1326-0373, Jahun, A.S. orcid.org/0000-0002-4585-1701 et al. (725 more authors) (2022) Genomic epidemiology of SARS-CoV-2 in a UK university identifies dynamics of transmission. Nature Communications, 13 (1). 751. ISSN 2041-1723

James, N., Pirrie, S., Pope, A. et al. (17 more authors) (2016) TRAPEZE: a randomised controlled trial of the clinical effectiveness and cost-effectiveness of chemotherapy with zoledronic acid, strontium-89, or both, in men with bony metastatic castration-refractory prostate cancer. Health Technology Assessment, 20. 53. ISSN 1366-5278

James, N.D., Pirrie, S.J., Pope, A.M. et al. (19 more authors) (2016) Clinical Outcomes and Survival Following Treatment of Metastatic Castrate-Refractory Prostate Cancer With Docetaxel Alone or With Strontium-89, Zoledronic Acid, or Both. JAMA Oncology, 2 (4). p. 493. ISSN 2374-2437